[Federal Register Volume 66, Number 80 (Wednesday, April 25, 2001)]
[Notices]
[Page 20821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-10198]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Sickle Cell Disease Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: June 4, 2001.
    Time: 8 a.m. to 5 p.m.
    Agenda: Discussion of program policies and issues.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9112, 9116, 6701 Rockledge Drive, Bethesda, MD 
20892.
    Contact Person: Charles M. Peterson, MD, Director, Blood 
Diseases Program, Division of Blood Diseases and Resources, National 
Heart, Lung, and Blood Institute, NIH, Two Rockledge Center, Room 
10158, MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435-
0050.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: April 18, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-10198 Filed 4-24-01; 8:45 am]
BILLING CODE 4140-01-M